Main Management ETF Advisors »

Sarepta Therapeutics shares owned by Main Management ETF Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Main Management ETF Advisors from 13F filings

Historical chart of Main Management ETF Advisors investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Main Management ETF Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Main Management ETF Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $678k 5.4k 124.82

More positions owned by Main Management ETF Advisors

Invesco Qqq Trust Series 1 (QQQ)
iShares S&P MidCap 400 Growth (IJK)
Select Sector Spdr Tr Communic etfeqty (XLC)
Vaneck Vectors Semiconductor Etf semiconductor (SMH)
Technology SPDR (XLK)
iShares S&P NA Tec.-SW. Idx. Fund (IGV)
Health Care SPDR (XLV)
iShares NASDAQ Biotechnology Index (IBB)
Ark Etf Tr gen rev mltsct (ARKG)
Consumer Discretionary SPDR (XLY)
Vanguard Energy ETF (VDE)
iShares S&P SmallCap 600 Index (IJR)
Franklin Templeton Etf Tr ftse japan etf (FLJP)
Franklin Templeton Etf Tr ftse china (FLCH)
iShares MSCI Netherlands Investable (EWN)

View all positions for Main Management ETF Advisors

Top funds holding Sarepta Therapeutics

BlackRock
BlackRock
Vanguard Group
Capital Research and Management Company - Division 3
State Street Corporation
Henderson Group
Morgan Stanley
Farallon Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
EcoR1 Capital
Citadel Advisors

View all funds holding Sarepta Therapeutics